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ABSTRACT 
Out of their niche environment, adult stem cells, such as mesenchymal stem cells (MSCs), 
spontaneously differentiate. This makes both studying these important regenerative cells and 
growing large numbers of stem cells for clinical use challenging. Traditional cell culture 
techniques have fallen short of meeting this challenge, but materials science offers hope. In this 
study we have used emerging rules of managing adhesion/cytoskeletal balance to prolong MSC 
cultures by fabricating controllable nanoscale cell interfaces using immobilized peptides that 
may be enzymatically activated to change their function. The surfaces can be altered (activated) 
at will to tip adhesion/cytoskeletal balance and initiate differentiation hence better informing 
biological mechanisms of stem cell growth. Tools that are able to investigate the stem cell 
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phenotype are important. While large phenotypical differences, such as the difference between 
an adipocyte and an osteoblast, are now better understood, the far more subtle differences 
between e.g. fibroblasts and MSCs are much harder to dissect.  The development of technologies 
able to dynamically navigate small differences in adhesion are critical in the race to provide 
regenerative strategies using stem cells. 
 
In vivo, adult stem cells reside within a specialized environment known as the niche. The niche 
is made up of cellular and non-cellular components including resident stem cells, support cells 
and extracellular matrix (ECM) that, together, regulate stem cell self-renewal.
1-4
 
Traditional culture plastics present a different environment to the in vivo niche and hence 
MSCs spontaneously differentiate to a heterogeneous population mainly made up of fibroblasts
5
. 
Thus, understanding and ultimately controlling MSC growth is desirable. 
In vitro materials-based strategies have been critical in understanding how cells adhere e.g. in 
showing that MSCs require a minimum patterned area of 69 μm
2 
of fibronectin per 1000 μm
2 
of 
surface in order for adhesions to form
6
 and that integrin composition and spacing is critical in 
integrin gathering and adhesion maturation.
7, 8
 As biomaterials can be used to control focal 
adhesion formation, they can thus be used to tune MSC phenotype.
9, 10
 It has been shown that if 
MSCs are allowed to spread, form large adhesions and develop a highly contractile cytoskeleton, 
they differentiate into osteoblasts.
11-16
 If, however, the MSCs are prevented from spreading, low 
intracellular tension and resultant adipogenesis follows.
11-16
 These rules have been devised using 
techniques such as microcontact printing of adhesive patterns,
11, 17, 18
 control of stiffness / 
crosslinking density,
12, 13, 19
 changing grafted chemistries,
20, 21
 employing stress relaxation
22, 23
 
and using defined nanotopographies.
24
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Of these, only nanotopography has been shown to also be able to facilitate prolonged MSC 
growth with retained multipotency.
5
 Enhanced MSC self-renewal required a slightly lower level 
of adhesion and cytoskeletal tension than on controls where spontaneous and untargeted 
differentiation to fibroblasts was observed.
25
 As MSCs have fibroblastic morphology,
26
 the 
morphology / adhesion / tension difference between a fibroblast and a MSC is small. Thus, as it 
is challenging to control cell tension so subtly, the rules for in vitro prolonged MSC growth with 
multipotency retained remain unclear and platforms able to achieve this are a scarce resource for 
the study of how stem cells work.  
An optimal cell/material interface would allow dynamic regulation of intracellular tension so 
that it would be possible to prove that altering the growth adhesion state results in differentiation. 
While examples of in situ change of surface properties exist, these switches involve uncaging 
and switching between inactive (no adhesion, cell quiescence) and active states (differentiation), 
thus are not suited to a more subtle regulation of adhesion required to probe stem cell growth. 
Dynamic culture systems are emerging largely based on light sensitive
27-29
 surfaces. Typically, 
a caging group is removed to reveal the cell adhesive tri-peptide RGD (arginine, glycine, aspartic 
acid) which binds integrins and hence regulates adhesion and intracellular tension.
27, 28, 30
 
The first MSC dynamic system involved MSCs adhering to pendular RGD incorporated within 
a polyethylene glycol (PEG) based hydrogel.
31
 Photocleavage was used to release the RGDs 
from the hydrogel resulting in chondrogenesis as the MSCs rounded up.
31
 While clearly 
demonstrating that it is possible to control cell fate using changes in cell adhesion this study had 
limitations as cell viability and expansion were limited in the hydrogels. Another study 
illustrated the potential for targeting osteogenesis from MSCs in 3D gels over short culture 
times, but control over cell growth was not achieved.
32
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Electro-active surfaces
33-35
 and protein responsive materials
36
 are also of interest in this area. 
However, these studies rely on non-biological chemistries and use of conducting 
materials/electrochemical potentials that may affect cell response and none have demonstrated 
ability to support prolonged multipotency or ability to modulate the environment to allow 
observation of changes that occur as differentiation is initiated. Recently, mechano-activated 
surfaces have gained interest based on concepts of opening of cryptic sites in proteins
37, 38
. 
We, however, chose to employ enzymatic activation to provide a natural stimulus to trigger 
changes in material properties, with advantages of biocompatibility and selectivity.
39
 Here we 
present a dynamic surface where both the caging group and the hidden group have discrete and 
tunable biological roles and show that adhesion can be subtly tuned to turn MSCs from a growth 
state with multipotency retained to a differentiating state that allows us to elucidate in vitro MSC 
growth mechanisms. 
 
RESULTS AND DISCUSSION 
SYNTHESIS OF USER CONTROLLED NANOINTERFACE 
Surfaces were synthesised by silanizing glass coverslips and covalently attaching a PEG 
monolayer onto which fluorenylmethyloxycarbonyl (FMOC)-amino acids were iteratively 
coupled using solid phase peptide synthesis directly on the PEGylated glass surface. The 
complete surface consists of the integrin binding RGD peptide or integrin inactive RGE peptide, 
followed by an elastase cleavable dialanine (AA) linker and then either FMOC as a steric 
blocking group, or PEG as an adhesion reducing blocking group. Hence, the final full sequences 
were either FMOC-AARGD/E or PEG-AARGD/E where D/E refers to RGD or RGE constructs. 
The FMOC protecting moiety sterically prevents cells fully interacting with the underlying RGD 
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ligands.
40
 Elastase removes the FMOC/PEG blocking group exposing RGD i.e. FMOC-
AARGD or PEG-AARGD where  refers to the cleavage point (Figure 1A and supplementary 
Figure 1). Using optimized protocols,
41
 synthesis was followed using a combination of solid-
state fluorescence spectroscopy (SSFS), water contact angle measurements and time-of-flight 
secondary ion mass spectrometry (Figure 1B and Supplementary figures 2&3).  
In order to activate the surface in situ, elastase concentration was optimized so the blocking 
group could be cleaved from the surface without affecting cell adhesion / viability. MSC 
adhesion/viability was assessed by incubating the cells with different elastase concentrations (1.0 
– 0.1 mg/ml (4.60 U – 0.460 U)) and using a live/dead stain. Between 1.0 and 0.4 mg/ml, MSCs 
rounded up and detached, while at 0.2 mg/ml some live cells remained attached though poorly 
spread. At 0.1 mg/ml, cell adhesion/viability was indistinguishable from controls (Figure 1C) 
and no detrimental affects were identified (Supplementary figure 4). SSFS confirmed that 0.1 
mg/ml elastase could cleave AA and remove FMOC (Figure 1D). TOF-SIMS was employed to 
indicate that after FMOC cleavage, RGD was still in place (Supplementary figure 5). Note that 
cleavage can be controlled as e.g. changing AARGD to phenylalanine (F)ARGD creates a shift 
from 29% to 50% FMOC cleavage respectively (supplementary figure 6) and this should allow 
control of how adhesive the surface is, or even permit sequential RGD% exposure to the cells. 
For FMOC blocking groups, uncleaved substrates are referred to as FMOC-RGD and FMOC-
RGE respectively, and cleaved substrates referred to as RGD and RGE. Plain glass, PEG18, RGD 
and RGE controls were also used, and PEG blocked substrates used in later experiments.  
 
DYNAMIC TARGETING OF MSC ADHESIONS 
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MSCs were seeded on plain, PEG18, RGD/E controls, FMOC-RGD/E and surfaces pre-treated 
with 0.1 mg/ml elastase to remove the FMOC blocking group (RGD/E). As expected, poor cell 
adhesion was observed on PEG18, RGE controls, FMOC-RGD/E, and cleaved RGE substrates. In 
comparison, cells seeded on plain, RGD controls and cleaved RGD surfaces adhered well 
(Supplementary figure 7); this is in line with hypothesized adhesion results (i.e. high adhesion on 
plain glass and surfaces with RGD exposed). Viability assay confirmed that all surfaces 
supported cell growth (Supplementary figure 6).  
Seeding density was also optimized and 75, 39 and 7 cells/mm
2 
tested. All samples were 
cultured for 7 days with half of the FMOC-RGD/E substrates cultured as uncleaved (or adhesion 
‘low’) for 48 hours before switching to cleaved (or adhesion ‘high’) using elastase (2 days ‘low’ 
and 5 days ‘high’). High cell density (75 cells/mm2) muted the effects of spreading from the 
‘low’ to ‘high’ state while lower cell densities (39 and 7 cells/mm2) exhibited markedly different 
degrees of cell spreading between these substrates (Supplementary figures 8-10). This is in 
agreement with previous reports illustrating reduction in cell-cell signaling is important to 
amplify cell-material signaling.
12
 7 cells/mm
2
 was selected as optimal as post-cleavage the MSCs 
acted as if on RGD control.  
Adhesion and resultant intracellular tension was further studied through vinculin (present in 
cell adhesions) and p-myosin (pSer 19 was chosen as it is phosphorylates Rho associated protein 
kinase involved in cytoskeletal contraction
11
) immunofluorescence. After 7 days of culture (2 
days ‘low’ and 5 days ‘high’ for cleaved substrates), adhesions were classified by length42 as 
focal complexes (FX, <1 µm), focal adhesions (FA, 1-5 µm) and super-mature adhesions 
(SMAdh, >5 µm). Imaging of vinculin and actin cytoskeleton demonstrated poor adhesion and 
few stress fibres in cells cultured on PEG18, RGE controls, FMOC-RGE, cleaved RGE and 
 8 
FMOC-RGD (low) substrates. In contrast, increased adhesion numbers and numerous stress 
fibres were seen in cells on plain, RGD controls and cleaved RGD (high) samples (Figure 2A). 
All observations thus fitted with the hypothesis that FMOC-RGD permitted only cells with a 
similar adhesion profile to RGE but as the surfaces were switched from the ‘low’ to the ‘high’ 
mode, larger cell adhesions became established, similar to RGD controls (Figure 2B, 
Supplementary figure 11),  
Considering p-myosin expression, the cells were observed to switch from a lower tension 
phenotype to a higher one when FMOC-RGD surfaces were enzymatically switched from ‘low’ 
to ‘high’. MSCs cultured on FMOC-RGD surfaces exhibited only slightly higher p-myosin levels 
with respect to cells cultured on RGE containing substrates while p-myosin expression for MSCs 
seeded on cleaved RGD surfaces was similar to levels expressed by cells cultured on the RGD 
control (Figure 2B). Critically, in line with nanotopographical studies, the number of SMAdhs 
and p-myosin expression was significantly lower on FMOC-RGD substrates than glass controls 
supporting that MSC growth requires a lower tensional state than fibroblastic growth.
5, 25
  
To ascertain if FMOC-RGD substrates do support MSC growth, cell proliferation was assessed 
on plain, FMOC-RGD, FMOC-RGE, and RGD and RGE controls by analysing 
bromodeoxyuridine (BrdU) uptake. Similar numbers of BrdU positive cells were observed at day 
1 of culture but by day 4, active proliferation was only significantly increased on FMOC-RGD 
(low) (Supplementary figure 12A). Furthermore, cell counts over 28 days showed cell expansion 
was greatest on uncleaved FMOC-RGD (low) in line with MSCs being faster growing than 
differentiated cells (supplementary figure 12B). Moving into functional analysis, we discounted 
all RGE and PEG18 substrates because cell numbers were considered too low to gather 
meaningful data. 
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To understand the first stages of differentiation related to adhesion we examined roles for 
integrins 1 (part of the fibronectin (FN) receptor) and 5 (can form part of the vitronectin (VN) 
receptor and has been identified previously as being important in MSC osteogenic 
commitment
43
), the bone morphogenetic protein 2 (BMP2) receptor BMPR1a and ezrin (anchors 
stress fibres to the cell membrane). After 48 hours of culture, elastase was added to half the 
cultures to reveal RGD (t0) and then receptor co-localisation followed for 48 hours. For MSCs on 
FMOC-RGD (low) substrates, adhesions were largely punctate and 1-based suggesting 
predominantly FN receptor mediated attachments with negligible BMPR1a co-localisation or 5 
expression (Figure 3A&B). However, on cleaved RGD (high) surfaces, MSCs were seen to 
express highly co-localised 5 and BMPR1a with elongate adhesion morphologies (Figure 3B). 
This data agrees with reports showing that cells bridge adhesions better using VN receptors 
allowing larger adhesions to form.
44
  
For ezrin, MSCs on FMOC-RGD (low) surfaces had close co-localisation of stress fibers and 
ezrin (Figure 3C). However, on cleaved RGD (high) surfaces, ezrin relocated becoming 
associated with cortical actin (Figure 3C). We can postulate that this allows for stress fiber 
remodelling required as the MSCs adapt to their new environments and increase adhesion. 
Indeed, if ezrin is knocked-down with siRNA, runt-associated transcription factor 2 (RUNX2, an 
osteogenic transcription regulator) phosphorylation, hence activation, increases (Figure 3C). 
 
CONTROLLING ADHESION RETAINS MSC PHENOTYPE 
Following on from observations of adhesion changes, we need to consider if these translate 
into ability to control phenotype. Thus, phenotypical analysis of the MSC growth markers 
STRO-1 and activated leukocyte cell adhesion molecule (ALCAM), and the osteoblast markers 
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osteopontin (OPN) and osteocalcin (OCN), were next used in longer-term cultures. The cells 
grew to form areas of confluence on glass, RGD controls, FMOC-RGD (low) and cleaved RGD 
(high) surfaces as could be seen at day 7 (2 days ‘low’ and 5 days ‘high’ for cleaved RGD; 
Supplementary figure 13). While MSCs on all surfaces and cells retained expression of STRO-1 
and ALCAM, it appeared that MSCs on the RGD controls and cleaved RGD (high) surfaces had 
started to express OPN and OCN. Image analysis for OCN at days 1, 3 and 5, however, showed 
negligible OCN at days 1 and 3 and a significant change in osteogenesis only on RGD controls 
(where cells had been exposed to RGD longest) at day 5 (Supplementary figure 14).  
By day 21 (2 days ‘low’ and 19 days ‘high’ for cleaved RGD), these differences were clear. 
On RGD controls and cleaved RGD surfaces, the cells expressed low levels of STRO-1 and 
ALCAM, and high levels of OPN and OCN (Figure 4A). Image analysis of STRO-1 expression 
at days 7, 14 and 21 illustrated a homogenous STRO-1 starting population at day 7 on all 
materials with STRO-1 levels then falling with time (Figure 4B). It is noteworthy that at day 14, 
STRO-1 levels were highest on the cleaved RGD  (high) surfaces possibly reflecting a lag due to 
the switch. However, by day 21, as osteogenic markers were expressed on the cleaved surface, 
STRO-1 expression was reduced to 15% of cells comparable to 12.2% in cells on the glass 
control. In contrast, on the FMOC-RGD (low) surface, 30.5% of MSCs retained STRO-1 
expression; MSCs could be removed from this surface after 21 day culture and multipotency 
demonstrated (supplementary figure 15).   
Quantification of OPN and OCN at 21 days of culture indicated that FMOC-RGD (low) and 
plain controls had low levels of bone marker expression while significantly elevated levels were 
observed on the RGD control and cleaved RGD surface (Figure 4C&D). In addition, we checked 
for the expression of chondrogenic (collagen II) and adipogenic (fatty acid binding protein, 
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FABP) markers. We observed negligible evidence for significant expression of either 
chondrogenesis or adipogenesis (supplementary figure 16) illustrating that targeted 
differentiation towards a high-tension phenotype, osteogenesis, was achieved on the RGD 
exposed surfaces.  Osteogenesis for MSCs on the RGD control and cleaved RGD (high) surfaces 
was confirmed at 28 days (Supplementary figure 17).  
 
ADHESION / PHENOTYPE CHANGES ARE REFLECTED IN MSC METABOLIC 
ACTIVITY 
To support phenotypical data, metabolomic analysis was carried out to gain deeper 
understanding of MSC metabolism during in situ activation as it has been previously shown that 
the stem cell metabolome becomes activated upon differentiation.
5, 25, 45, 46
 Untargeted mass 
spectrometry analysis of metabolites from MSCs cultured on FMOC-RGD (low) at 2 and 4 days 
vs MSCs on plain controls at similar time points, showed only a slight metabolomic change 
between both time points (figure 5A&B). However, when FMOC was then cleaved from the 
surface on day two to reveal the RGD ligand (high) and cultured for a further two days, changes 
became highly significant, i.e. metabolome activation was observed (Figure 5C). When the 
culture time was expanded to 7 days (2 days ‘low’ and 5 days ‘high’ for cleaved RGD), 
metabolic differences increased. Principle component analysis showed that the FMOC-RGD 
(low) metabolome was more homogeneous than for MSCs on plain control or cleaved RGD 
(high) surfaces where heterogeneous metabolomic profiles were identified (figure 5D). It has 
also been proposed that self-renewing embryonic stem cell
45
 and MSC
5
 populations pool 
unsaturated metabolites to allow for redox plasticity; this trend is seen in the lipid metabolites in 
this current study (figure 5E). 
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Ingenuity
®
 Pathway Analysis allowed us to observe that fewer metabolic pathways were 
differentially regulated with less significance in MSCs on the FMOC-RGD (low) surface 
compared to on the cleaved RGD (high) surface (figure 5F&G). These include pathways 
involved in energy (energy production, lipid and carbohydrate metabolism), growth (cell 
proliferation and nucleic acid metabolism), protein (post-translational modification and cellular 
development) and skeletal development. Furthermore, most highly modulated networks for 
MSCs on FMOC-RGD (low) illustrated metabolic regulation linked to cell growth control. When 
similar networks were considered for cells on cleaved RGD (high), metabolic regulation 
appeared less significant (Supplementary figures 18&19). 
 
LONG-TERM MSC GROWTH CONTROL 
Next, we wanted to examine if our ‘low’ maintenance state could work for prolonged cultured 
before switching to ‘high’ thus further demonstrating that adhesion was responsible for 
growth/osteogenesis. Thus, we cultured the MSCs for 2 weeks rather than 2 days before adding 
elastase and then allowed the cells to grow a further 2 weeks before staining for STRO-1. With 
the longer time to trigger, loss of STRO-1 on the cleaved RGD surface (high) was not seen 
suggesting retention of multipotency rather than differentiation (Supplementary figure 20). 
Working to the hypothesis that the FMOC group becomes coated in ECM proteins reducing 
elastase efficiency, we substituted the FMOC blocking group for PEG to reduce protein 
adsorption.  
As with FMOC-RGD, MSCs were seen to expand on PEG-RGD and retain STRO-1 
expression, which was reduced on plain controls (Figure 6A&B). However, unlike with FMOC, 
switching from PEG-RGD to its corresponding cleaved counterpart resulted in focal adhesion 
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elongation and reduction in STRO-1 demonstrating that stimulus-initiated cell differentiation 
with elastase could be achieved with longer culture (figure 6A&B). Metabolomic analysis after 7 
days culture (2 days ‘low’ then 5 days ‘high’ for cleaved RGD) again showed that the inactive 
RGD surface (PEG-RGD) had the most homogeneous metabolome, while cleaved RGD surfaces 
had a more heterogeneous metabolome indicative of a change from MSCs to differentiating 
phenotype (figure 6C). 
 
 
SUMMARY AND CONCLUSIONS 
This report provides evidence that the MSC adhesion ‘footprint’ permits control of MSC 
growth and targeted differentiation. Using enzyme cleavable surfaces, it is shown that increasing 
adhesion causes lineage commitment. This report addresses a major research focus of MSC 
biology – how do they regulate multipotency.  MSCs are shown to walk an extremely fine line 
between controlled growth with multipotency and spontaneous fibroblast differentiation. We 
propose from our data that a small reduction in adhesion by controlling integrin subunit use 
prevents metabolome activation with associated energy demand required for differentiation; a 
larger reduction in adhesion and tension would result in adipogenesis.
11, 17
 On the same surface, 
we demonstrate that a switch from FN to VN receptor facilitates both adhesion and BMP 
signaling to switch from stem cell growth to osteogenic commitment through increased levels of 
intracellular tension. We note that our analysis relies largely on binning adhesion length and that 
analysis in X, Y and Z may yield further information.
47, 48
 However, we show that length gives 
an effective, easy to use, differentiation between MSC states of self-renewal and osteogenesis. 
Further, we postulate, from ezrin observations, that potential cytoskeleton de-coupling from the 
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membrane during changes in adhesion dynamics can accelerate the commitment to 
differentiation. 
We illustrate that we can refine our protocols by switching from FMOC to PEG to create a 
surface that is both amenable to longer-term dynamic culture and is made from all biocompatible 
building blocks. This, and the ability to control degree of cleavage by switching peptide 
sequence (supplementary figure 6) is a clear advantage of our surfaces.  
We present a dynamic surface that clearly shows that the adhesion /tension balance 
relationship between a fibroblast (the ‘lab weed’) and MSCs (a stem cell with major regenerative 
potential) is small. It is thus exciting that materials can be designed to enhance MSC growth and 
to study lineage commitment in a dynamic manner. 
 
 
MATERIALS AND METHODS 
 
Unless otherwise stated reagents are from Sigma, UK. Raw data has DOI number: 
doi.org/10.5525/gla.researchdata.324 
 
Surface Modification 
Substrates were synthesised as previously described
40
 using FMOC protected L-amino acids. 
Glass coverslips were sonicated in acetone, ethanol, methanol then deionised water (20 minutes 
each). Afterwards coverslips were cleaned for 1 hour using a 3:7 piranha solution of 30% 
hydrogen peroxide and concentrated sulphuric acid to remove organic contaminants then 
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individually washed in copious amounts of deionised water, dried under nitrogen and left at 75C 
overnight. Once dry, surfaces were functionalised with amine groups as per Piehler et al.,
49
 to 
facilitate direct attachment of amino acids during SPPS. To achieve this, surfaces were silanized 
using (3-Glycidyloxypropyl) trimethoxysilane (GOPTS) at 37C for 1 hour, then washed with 
acetone and dried under nitrogen. A diamine functionalised polyethylene glycol powder (O, O’-
Bis(2-aminoethyl)octadecaethylene glycol, PEG; CAS no 892154-56-2) was melted onto the 
surfaces at 75C for 48 hours to attach the PEG linker through reaction of the epoxy groups on 
the surface, with the amine groups on the PEG. Surfaces were cleaned in deionised water to wash 
off the unbound PEG and then dried under nitrogen. 
To build up the peptide chain using SPPS, a three-step procedure was applied. In step 1, the 
first FMOC protected amino acid (0.2 mmol) was coupled to the PEG monolayer in a solution of 
ethyl-(hydroxyimino) cyanoacetate (oxyma, 0.4 mmol) and N,N’-diisopropylcarbodiimide (DIC, 
0.4 mmol) per 10 ml of anhydrous N,N-dimethylformamide (DMF). Samples were submerged in 
solution for 2 hours and gently agitated on an orbital shaker to allow continued mixing of 
reagents and removal of by-products from the sample surface. After this time, samples were 
rinsed in DMF, ethanol, methanol and DMF (5 minutes each using agitation). A fresh reaction 
solution containing the same amino acid was prepared and added to samples, which were then 
left overnight under the same conditions described above. Washing stages using DMF, ethanol, 
methanol and DMF as previously outlined.  
For the second step, FMOC groups were removed (deprotected) using piperidine (20% in 
DMF) for 2 hours under agitation, followed by washing steps. Subsequent additions of FMOC 
protected amino acids were carried out repeating steps 1 and 2 until the desired peptide sequence 
was obtained. The terminating FMOC groups were left in place. The final step (step 3) was to 
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remove side-chain protecting groups on aspartic acid and glutamic acid residues (O-tert. Butyl; 
OtBu) and arginine (pentamethyldihydrobenzofuran-5-sulfonyl; Pbf) with a 90% solution of 
aqueous trifluoroacetic acid (TFA) for 4 hours. Samples were washed and dried then stored 
under vacuum in a desiccator or used straight away. For surfaces terminating in a PEG blocking 
group (i.e. PEG-AARGD-), the peptide chain was built up as per the method for FMOC surfaces 
with an additional step to remove the terminating FMOC with piperidine. PEG (O-methyl-O’-
succinyl polyethylene glycol 2’000, CAS no: 31961-02-1) was then added to the terminal amino 
acid prior to the side-chain protecting groups being removed. 
FMOC and PEG blocking groups were removed in situ by enzymatic cleavage using porcine 
pancreatic elastase (Worthington Biochemical) which was reconstituted in basic culture media 
and filtered through 0.22 µm. Throughout this work the same bottle was used and certified as 
having an enzymatic activity of 4.61 units/mg where 1 unit (U) converts 1 μmole of N-succinyl-
trialynyl-p-nitroanilide per minute at 25°C.  
 
 
Stepwise Monitoring of Solid-Phase Peptide Synthesis 
Water Contact Angle  
Water contact angle (WCA) was carried out using the sessile drop technique with a KSV CAM 
100 contact angle goniometer (KSV Instruments, USA). High contrast images of static water 
droplets were recorded and CAM 100 software was used to apply a circular fit to the droplet 
outline to determine contact angles across a series of measurements. A total of three droplets 
were recorded per surface (25 frames per droplet) and three of each surface used. Averages were 
pooled for the main data.  
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Solid State Fluorescence Spectroscopy 
After each coupling and deprotection stage, samples were taken from the bulk batch after the 
methanol washing stage and rinsed in distilled water followed by drying under nitrogen. Samples 
were analysed using fluorescence spectroscopy (FS) to confirm the attachment of the FMOC-
protected amino acids, and removal of the FMOC group during coupling and deprotection stages. 
This technique is as described in literature by Zelzer et al. 
50
 taking advantage of the fluorescent 
properties of the FMOC group. Fluorescence spectra were measured at room temperature using a 
JASCO FP-6500 spectrophotometer (JASCO, JPN) with spectra manager™ software. Samples 
were attached to a glass microscope slide inserted into a custom-made rotatable holder within the 
spectrophotometer chamber. Samples were orientated at 30 degrees to the incident light to limit 
the amount of reflected excitation light hitting the detector. Excitation of the surface-tethered 
FMOC groups was carried out using an excitation wavelength of 270 nm with a slit width of 20 
nm. Three spectra were recorded at each stage of synthesis using three different samples. 
 
Cell culture 
STRO-1 Selected MSCs  
Skeletal STRO-1
+
 MSCs were derived from bone marrow obtained from haematologically 
normal patients undergoing routine total hip replacement surgery with the approval of 
Southampton General Hospital Ethics Committee; only tissue that is normally discarded was 
used. Cells were aspirated from trabecular bone marrow samples and centrifuged at 250 g for 4 
minutes at 4C. The cell pellet was resuspended in -MEM and passed through a 70 µm pore 
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nylon mesh (BD Biosciences). Red blood cells were removed by centrifugation with lymphoprep 
gradient solution (Robbins Scientific) and the remaining cells in the buffy layer resuspended in 
10 ml of blocking solution (4-(2-hydroxyethyl)-1-piperazine-ethanesulphonic acid (HEPES)) 
saline solution with 5% v/v foetal calf serum, 5% v/v human serum and 1% w/v bovine serum 
albumin (BSA). Afterwards the cells were incubated with a STRO-1 antibody in hybridoma 
supernatant (hybridoma courtesy of Dr Beresford, University of Bath) and flushed with magnetic 
cell separation (MACS) buffer (Miltenyi Biotec) to remove any excess antibody. The cells were 
incubated with human anti-IgM magnetic microbeads (Miltenyi Biotec, UK) then added to a 
magnetic column; the eluent was collected as the STRO-1
-
 fraction. After washing with MACs 
buffer without the magnetic field, the eluted cell population was collected as the STRO-1
+
 
fraction. Skeletal MSCs purchased from Promocell were used for metabolomics experiments. 
 
MSC Maintenance and Experiment Preparation 
MSCs were maintained at 37C and 5% CO2 in -MEM (PAA Laboratories) supplemented 
with 10% v/v foetal bovine serum (FBS) and 2% v/v antibiotic mix (60% v/v L-Glutamine, 35% 
v/v penicillin streptomysin and 5% v/v Ampotericin B). For all experiments cells were rinsed in 
HEPES saline solution (150 mM NaCl, 5 mM KCl, 5 mM Glucose, 10 mM HEPES and 0.5% 
v/v phenol red indicator adjusted to pH 7.5), followed by 4 ml of trypsin-versene solution (0.5% 
v/v trypsin and versene: 150 mM NaCl, 5 mM KCl, 5 mM Glucose, 10 mM HEPES, 1 mM 
ethylenediaminetetraacetic acid (EDTA) and 0.5% v/v phenol red indicator adjusted to pH 7.5) 
until cells were detached from the tissue culture flask. Detached cells were transferred to a sterile 
falcon tube and centrifuged at 376 g for 4 minutes. The supernatant was discarded and the cell 
pellet resuspended in 5 ml of fresh -MEMs. Cell numbers were counted using a Neubaur 
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haemocytometer and seeded as per experimental setup. Prior to use, substrates were sterilised 
with 70% ethanol (3x 5 minutes) then washed with HEPES saline solution and basal -MEM. 
 
Coomassie Blue Staining 
To assess cell adhesion, MSCs were fixed 10% v/v formaldehyde/PBS for 15 minutes at 37C 
then stained with coomassie blue protein dye (0.5% w/v coomassie brilliant blue R-250 dissolved 
in 4:1 methanol:acetic acid and filtered with Whatman filter paper) for 15 minutes at room 
temperature. Excess stain was removed by washing samples with water until areas around the 
cells were clear. Images were taken using a Zeiss Axiovert inverted light microscope at 10X 
magnification (0.25 NA) with a Qimaging digital CCD camera (Qimaging, Canada) and 
Qcapture
TM
 software; n=3. 
 
Elastase Tolerance 
For elastase tolerance, MSCs were seeded onto plain glass coverslips and left to adhere for 48 
hours. Porcine pancreatic elastase was dissolved in -MEMs at 37C as a stock solution and then 
filter sterilised through a 0.22 µm syringe filter. The stock solution was diluted across a 
concentration range of 1.0–0.1 mg/ml (4.61-0.461 units) and added to samples in place of -
MEMs (controls were maintained in basic -MEMs). MSCs were incubated for a further 24 
hours then examined for detachment using a Zeiss Axiovert inverted light microscope at 10X 
magnification (0.25 NA) with a Qimaging digital CCD camera (Qimaging, Canada) and 
Qcapture
TM
 software; n=3. 
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Live/dead staining 
For live/dead staining during elastase tolerance, cells were seeded onto plain glass coverslips 
as described in Elastase Tolerance section, and cultured for 24h in -MEM, followed by a 
further 24h of culture in medium containing the titrated concentrations of elastase (4.61-0.461 
units and controls). Additional ‘dead’ control cells were cultured in the absence of elastase, and 
70% ethanol added to kill the cells prior to staining. Culture media was removed and cells were 
washed twice in warm phosphate-buffered saline (PBS), which was then replaced with live/dead 
assay reagents (2 μM calcein AM and 4 μM ethidium homodimer-1 in PBS), and incubated at 
room temperature until colour development occurred (approximately 15 mins in the dark). The 
stain was removed and the cells were rinsed twice in warm PBS, and imaged using a Zeiss 
Axiovert fluorescence microscope. 
For live/dead staining of cells cultured on the panel of surfaces, cells were cultured on plain 
controls, PEG18, RGD and RGE controls, FMOC-RGD and FMOC-RGE (see supplementary 
figure 2 for corresponding peptide sequences) for 24h in -MEM.  Dead control cells were 
prepared by adding 70% ethanol to cells cultured on plain coverslips after 24h. The cells were 
stained and imaged as described above. 
 
Proliferation assay 
Cells were cultured on plain glass coverslips, plain controls, PEG18, RGD and RGE controls, 
FMOC-RGD and FMOC-RGE substrates in -MEM, and pulse-labelled with 10 μM 5-bromo-2-
deoxyuridine (BrdU) for 4h prior to fixation for 1 day and 4 day time points. BrdU positive 
MSCs were visualised as described in Immunocytochemistry. 
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Phenotype characterisation pre- and post-trigger 
Cells were seeded on to plain glass coverslips, RGD controls and FMOC-RGD surfaces and 
cultured in standard -MEM (see MSC maintenance and experiment preparation for culture 
media composition). To cleave the FMOC blocking group, the culture medium was replaced 
with medium containing 0.1 mg/ml elastase for 2 days then replaced with standard -MEM for 
the remaining length of culture. The cells were cultured for a total of 2 weeks. 
 
Induction medium experiment 
Cells were cultured for 2 weeks on plain controls and FMOC-RGD surfaces in standard -
MEM. After this time, samples were divided into 3 groups; control groups cultured in standard 
-MEM, osteogenic cultures incubated with osteogenic induction media (350 μM ascorbate-2-
phosphate, 0.1 μM dexamethasone in DMEM with 10% FBS), and adipogenic cultures that were 
alternated between adipogenic induction media (1 μM dexamethasone, 1.7 nM insulin, 200 μM 
indomethacin, 500 μM isobutylmethylxanthine in DMEM with 10% FBS, L-glutamine and 
antibiotics) and maintenance medium (1.7 nM insulin in DMEM with 10% FBS, 200 mM L-
glutamine and antibiotics). The 3 groups were cultured for 4 weeks before fixation; n=3 
replicates of each surface per group.  
 
Cell population marker analysis 
Cells were seeded onto plain controls, RGD controls and FMOC-RGD substrates. Half of the 
FMOC-RGD surfaces were cleaved by replacing the culture medium with medium containing 
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0.1 mg/ml elastase after two days of culture. Cells were fixed after 24 hour, 3 day and 5 days of 
culture as per the method described in Immunocytochemistry. 
 
Immunocytochemistry  
Samples were washed with PBS and fixed with 10% v/v formaldehyde/PBS for 15 minutes at 
37C. Cells were permeabilised at 4C for 5 minutes (30 mM sucrose, 50 mM NaCl, 3 mM 
MgCl2.6H2O, 20 mM HEPES and 0.5% v/v Triton® X-100 in PBS adjusted to pH 7.2) and non-
specific binding epitopes were blocked with 1% w/v BSA/PBS for 15 minutes at 37C (this step 
was omitted for anti-BrdU staining). Primary antibodies were made up in PBS/BSA with 
rhodamine-phalloidin (1:500; Molecular Probes) with either: 
1. Mouse monoclonal anti-vinculin IgG (1:150; Sigma) for adhesion analysis. 
2. Mouse monoclonal anti-phosphomyosin IgG (1:200; Cell Signaling Technology) for 
phosphomyosin studies. 
3. Mouse monoclonal anti STRO-1/OPN/OCN IgG (1:50; Insight Biotechnology) or rabbit 
polyclonal anti-ALCAM IgG (1:50; Epitomics) for phenotype analysis and cell population 
marker analysis.  
4. Mouse monoclonal anti-BrdU (clone BU-1, 1:100 in nuclease solution, prepared according 
to the manufacturer’s instructions in kit RPN202; GE Healthcare) for proliferation studies. 
Rhodamine-phalloidin was added with the secondary rather.than the primary antibody. 
5. Rabbit polyclonal anti Fatty acid binding protein (FABP; 1:50; Abcam) or rabbit polyclonal 
anti collagen II (COL2A, 1:50; Insight Bio) for cell phenotype pre- and post-trigger. Rhodamine-
phalloidin was added with the secondary antibody for collagen II. 
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6. Rabbit polyclonal anti RUNX2 (1:50; Insight Bio) or mouse monoclonal anti vimentin 
(1:50; Sigma) for elastase experiments. 
7. Rabbit polyclonal anti Ezrin/Radixin/Moesin (Cell Signaling Technology; 1:50) for Ezrin 
expression. 
Samples were incubated for 1 hour (1.5h for anti-BrdU) at 37C after which time they were 
washed in 0.5% v/v Tween 20/PBS (PBST, 3x 5 minutes under gentle agitation) to minimise 
background labelling. Horse biotinylated anti-mouse IgG (1:50; Vector Laboratories) or horse 
biotinylated anti-rabbit IgG (Vector Laboratories) BSA/PBS was added to samples and incubated 
for 1 hour at 37C. After washing stages, samples were incubated for 30 minutes at 4C with 
fluorescein isothyiocyanate streptavidin (FITC; 1:50; Vector Laboratories) in BSA/PBS followed 
by a final washing stage. Coverslips were placed on glass slides in 4’6-diamidino-2-phenylindole 
(DAPI) mountant (Vector Laboratories).  
Cells imaged for adhesions analysis were visualised using a Zeiss Axiophot fluorescence 
microscope at 20X magnification (0.40 NA). Images were captured using an Evolution QEi 
digital monochromatic CCD camera (Media Cybernetics, USA) with Qcapture
TM
 imaging 
software. Cells imaged for phosphomyosin and phenotype analysis were imaged with a Zeiss 
Axiovert fluorescence microscope at 20X magnification (0.50 NA), and studies at 40X (0.40 
NA). Axiovert images were taken using an Evolution QEi digital monochromatic CCD camera 
(Media Cybernetics, USA) with ImagePro software.  
 
Double immunostaining for co-localization studies 
Cells seeded on FMOC-RGD substrates were cultured for 2 days. After this time, control cells 
were cultured in standard culture media while test samples were incubated with 0.1 mg/ml 
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elastase for 24 and 48 hours. Co-localization of BMPR1A with the integrins β1 and β5, was 
performed using immunocytochemistry in the previous section. After fixation, samples were 
incubated with a primary antibody cocktail consisting of rabbit polyclonal anti BMPR1A 
(Thermo Scientific; 1:50), mouse monoclonal anti-integrin β1 (Thermo Scientific; 1:50) and 
mouse anti-integrin αvβ5 (R&D system, 1:50) in 1% of BSA/PBS. Secondary antibodies were 
Texas red anti-mouse (Vector laboratories; 1:50) for integrin β1 and β5, and biotinylated anti-
rabbit (Vector laboratories) lconjugated with FITC for BMPR1A. 
Cells imaged for co-localization of BMPR1A with integrin β1 and β5 were visualised using a 
Zeiss Axiophot fluorescence microscope at 40X magnification (0.75 NA). Images were captured 
using an Evolution QEi digital monochromatic CCD camera (Media Cybernetics, USA) with 
Qcapture
TM
 imaging software. 
 
RNA Interference 
RNA interference was performed using Non-targeting SiRNA (Cat No: D001810-01-05) and 
human Ezrin-SiRNA (Cat No: L-017370-00) purchased from GE Healthcare. Transfections were 
carried out using DharmaFECT
TM 
Transfection Reagents (GE Healthcare) according to the 
manufacturer’s instructions. 
 
In Cell Western 
Cells on substrates were washed with PBS and fixed with 10% v/v formaldehyde/PBS for 15 
minutes at 37C. Cells were permeabilised using pre-cooled methanol at 4C for 10 minutes, and 
non-specific binding epitopes were blocked with 1% milk protein in 0.1% Tween 20/PBS 
(PBST) for 1 hour at room temperature. Cells were then washed three times (3x5 minutes) with 
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0.1% PBST. Primary antibodies diluted in 1% milk/PBST containing Cell Tag 700CW stain 
(1:500; LI-COR, Cat No: 926-41090) with either:  
1. Rabbit polyclonal anti Ezrin/Radixin/Moesin (Cell Signaling Technology; 1:50) for Ezrin 
knocking-down efficiency measurement. 
2. Rabbit polyclonal RUNX2 (Santa Cruz; 1:50) RUNX2 expression in Ezrin knocking-down 
cells. 
3. Rabbit polyclonal Phospho-RUNX2 pSer465 (Thermo Scientific; 1:50) for Phospho -
RUNX2 expression in Ezrin knocking-down cells. 
Cells with primary antibody were incubated at room temperature for 1 hour, and then washed 
with 0.1% PBST for three times. After washing, Cells with secondary antibody - either IRDye 
800CW, Goat anti-mouse (LI-COR, Cat No: 926-32210) or Donkey anti-rabbit (LI-COR, Cat 
No: 926-32213) diluted in 1% milk/PBST at 1:1000 were incubated at room temperature for 1 
hour or at 4
0
C for overnight. After washing stage, cells were subjected to LI-COR Odyssey Sa 
(0157) scanner. The protein of interest was scanned at channel 800, and CellTag at channel 700 
(scan parameters: Focus offset = 2.0mm, scan resolution = 100µm, intensity = 12). Data were 
collected in integrated intensity (IntegInten), and analysed by one-way analysis of variance 
(ANOVA) and Dunn’s post-hoc test applied where significance was determined as p<0.05. 
 
 
Image Analysis 
Fluorescence microscopy images were exported to Adobe Photoshop
®
 for the purpose of 
labelling and superimposing colour channels. For size analysis, actin images were exported to 
ImageJ (http://rsbweb.nih.gov/ij/download.html) to calculate cell area using the threshold tool. 
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For adhesion analysis, vinculin images were exported to Adobe Photoshop
®
 and each individual 
adhesion traced with a 1-pixel width line to create an adhesion mask superimposed over the 
background image. ImageJ was then used to determine total adhesion numbers and length; 
individual subtypes were plotted as a percentage of the overall number of adhesions recorded. 
For the proliferation analysis, the percentage of BrdU positive cells were quantified for at least 
150 cells per sample type, and normalised to determine the percentage change relative to the 
glass controls. Analysis of the maintenance of Stro-1+ expression of staining over time was 
performed by allocating cells into categories (at least 50 cells per surface type) indicating the 
features of the staining.  
In order to determine phosphomyosin expression, or Stro-1+ expression for cell population 
analysis (at least 50 cells per sample type), greyscale images were exported into ImageJ and 
individual cells selected with the polygon tool. Using the method as described in Burgess et al., 
51, 52
 phosphomyosin expression was calculated using integrated density (ID) values where ID = 
(area x mean grey value). Calculations were then corrected for background fluorescence using 
the formula: ID – (cell area x ID of background fluorescence). In order to quantify the expression 
of phenotypic markers, fluorescence images were exported to ImageJ and highlighted with the 
threshold tool. Integrated density values (area x mean grey value) were recorded and these values 
divided by the number of nuclei to average fluorescence across the number of cells in the same 
field of view. As the background fluorescence could not be recorded because of cell confluency, 
only images taken at similar exposure levels were used.  
Data was analysed by one-way analysis of variance (ANOVA) and Dunn’s post-hoc test 
applied, or t-tests to identify any significant differences between the groups; where significance 
was determined as p<0.5. 
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MTT assay 
After 5 days, 100 µl of 5 mg/ml MTT (methylthiazolyldiphenyl-tetrazolium bromide) solution 
in complete cell culture media was added to the cells for 2 hours. After this time, the media was 
removed and replaced with DMSO for 5 minutes. Liquid from each well was then analysed at 
570 nm (background set to 670 nm) and optical density reported. 
 
 
Metabolomics 
For metabolomic analysis, substrates were removed from the well plates and transferred to new 
sterile plates so that only cells that were attached to the substrates were used in the analysis. 
Substrates were washed once with warmed PBS then 0.5 ml of ice-cold extraction solvent 
(chloroform: methanol: water at 1:3:1 v/v) was added to the wells. Plates were sealed with 
parafilm to minimise evaporation and placed on a rotary shaker for 1 hour at 4C. After this time 
the extraction solvent was transferred to sterile 0.5 ml eppendorfs and centrifuged at 13,000 g for 
5 minutes to remove cell debris. The supernatant was transferred to LC vials otherwise samples 
were stored at -80C in eppendorf tubes until use. For elastase studies, all samples were 
processed in-well with 150 µl of extraction solvent added to each well. Samples were then 
processed as above. 
All samples were diluted 1 in 2 with acetonitrile prior to being aspirated to HPLC vials; an 
additional 5 µl of each sample was combined into a single aliquot to be used as a quality control 
sample. This pooled sample was injected several times throughout the duration of each run in 
order to monitor metabolite quality and sample degradation. Three standards containing a 
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number of known metabolites were also run alongside unknown samples for the purpose of 
identifying all other metabolites. Chromatographic separation of metabolites was performed 
using an UltiMate 3000 RS-LC (Thermo Fisher) with a zwitterionic hydrophilic interaction 
liquid chromatography (ZIC-HILIC) column (C18 150 x 4.6mm; Merck Sequant) as the 
stationary phase, 1% v/v formic acid in acetonitrile as the organic mobile phase, and 1% v/v 
aqueous formic acid as the aqueous mobile phase. The mobile phase was run as a gradient over 
46 minutes (table 1). Injection volumes were 10 µl and a ZIC-HILIC C8 20 x 2.0 guard column 
was used to protect the main column from impurities; chromatography columns were maintained 
at 25°C. 
 
 
Time 
(min) 
 
 
Aqueous 
(%) 
 
 
Organic 
(%) 
 
 
Flow rate 
(ml/min) 
 
 
Gradient 
curve 
 
     
0 20 80 0.3 1 
30 20 80 0.3 6 
32 80 20 0.3 6 
40 95 5 0.3 6 
42 95 5 0.3 6 
Table 1: LC-MS mobile phase parameters. Chromatographic separation of metabolites was 
carried out using an organic (1% v/v formic acid in acetonitrile)/aqueous (1% v/v aqueous formic 
acid) mobile phase run over a period of 46 minutes. Table data shows the percentage of each 
mobile phase at particular time points, flow rate and gradient curve conditions.  
MS was performed using an Orbitrap Exactive accurate mass mass spectrometer (Thermo 
Fisher Scientific). Scans were conducted at a mass resolution of 50,000 in both positive and 
negative ion modes across a range of 70-1400 m/z. Prior to data acquisition, mass calibration 
was performed in positive and negative modes using a calibration mix containing a number of 
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compounds with known masses across the acquisition range. Data conversion, chromatographic 
peak selection, and metabolite identification were carried out using the IDEOM/MzMatch Excel 
Interface 
53, 54
, and chromatographic peak intensities (peak area under the curve) were normalised 
against calculated protein content. Known standards were used to define both mass and retention 
times of analytes. Putative metabolites were also identified on this basis using predicted retention 
times as described in Creek et al. 2011
55
. MetaboAnalyst
56
 and Ingenuity pathway analysis were 
used to generate illustrations. 
 
Time of Flight Secondary Ion Mass Spectrometry (ToF-SIMS) 
ToF-SIMS analysis was carried out with a ToF-SIMS IV time of flight instrument (ION-TOF 
GmbH). Secondary ions were generated using a primary ion beam from a 25 kV Bi3
+
 liquid 
metal ion source with a 1 pA pulsed target current. The primary ion dose was kept below the 
static limit (less than 2.45 x 10
12
 ions per cm
2
). Built up surface charge was compensated using 
an electron gun producing a flux of low energy electrons (20 eV). Secondary ions were subjected 
to a post acceleration voltage of 10 kV and analysed with positive polarity with a single stage 
reflectron analyzer. Images were acquired by rastering the primary ion beam across the sample 
surface. On each sample, two small scale (500 μm x 500 μm; 2 μm resolution) and one large 
scale (3 mm x 3 mm; 10 μm resolution) areas were imaged. 
The data was processed using Surface Lab 6. Mass spectra were calibrated to known reference 
peaks from H
+
, CH3
+
, C2H5
+
, C3H7
+
 and C4H9
+
. Peaks from the samples were assigned to PEG, 
FMOC and the amino acids according to reference data from the literature
40, 57, 58
. Ion intensity 
images were generated from these ions of interest by the software.  
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For qualitative assessment of sample uniformity and presence of chemical functionalities, 
small scale images (500 μm x 500 μm) were used and the ions associated with amino acids were 
summed up and combined in a single image. The ion count scale for specific ion images (PEG, 
FMOC, amino acids) were manually adjusted to the same range for each sample to allow direct 
comparison. Total ion images were scaled individually.  
For semi-quantitative assessment of the relative amount of FMOC removed from the surface, 
the large scale images (3 mm x 3 mm; one per sample type) were normalised to the total ion 
counts and divided into four regions of interest (ROI) that correspond to four equally sized, non-
overlapping quadrants (1.5 mm x 1.5 mm) of the image. Normalised ion intensities for an FMOC 
related ion (C14H11
+
, m/z = 179) were generated for each ROI by the software to provide four 
datasets for each sample that were used to calculate a mean and standard deviation for the FMOC 
ion intensities before and after exposure of FMOC-AARGD and FMOC-FARGD to elastase. 
These normalised intensities were used to calculate a percentage decrease of FMOC on the two 
sample types. It should be noted that this method to generate numeric data of surface densities of 
chemical compounds is sensitive to small amounts of material on the surface but not fully 
quantitative due to a variety of factors affecting measured ion intensities from ToF-SIMS 
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Figure 1: Dynamic, enzyme cleavable surfaces for MSC growth. (A) Cartoon 
representation of the FMOC and PEG blocked RGD surfaces illustrating the elastase 
cleavage site. Plain glass coverslips were modified using silanization and pegylation steps 
followed by solid-phase peptide synthesis to build up the full structure in a stepwise 
manner. The incorporation of a dialanine enzyme cleavable linker facilitates the removal of 
the FMOC/PEG blocking group thereby forming the basis of the switch. (B) TOF-SIMS 
image shows a uniform chemical surface composition on the micron scale and confirms 
that PEG, FMOC and amino acids (shown as the sum of the indicated representative peaks 
for each amino acid) are only detected in the analysis where expected – i.e. FMOC only seen 
on the FMOC-D surface and amino acids only noted when the AARGD sequence was 
present. Color scales represent ion counts. Images for specific ions are presented on the 
same scale for all samples; total ion images are scaled to their individual range. Note that 
inset images in the Fmoc column are all similarly brightness-enhanced versions of the main 
images to show differences more clearly. (C) MSCs were cultured on plain glass coverslips 
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for 48 hours then treated with different concentrations of elastase ranging from 1.0 to 0.1 
mg/ml (4.60 U to 0.460 U) in basal cell culture medium. Live/dead stain for elastase 
tolerance showed that while cell adhesion was clearly affected at the higher concentrations, 
few remaining dead cells were noted with any elastase concentration (they may have 
detached). However, cells incubated with 0.1 mg/ml elastase were indistinguishable from 
controls while the positive controls (ethanol addition) indicated uptake of the ethidium 
homodimer thus these cells were dead.  (D) Surface-bound FMOC groups were seen to 
fluoresce at a wavelength of 315 nm (left-hand spectrum) and piperdine cleavage resulted 
in a loss of this signal (middle spectrum). At 0.1 mg/ml it was seen that elastase cleaved 
surface-bound FMOC (right-hand spectrum); n=3.  
 
Figure 2: Dynamic control of MSC adhesion and tension. (A) MSCs cultured at 7 
cells/mm2 were seen to spread to a greater degree on plain controls, RGD controls, FMOC-
RGD (low) and cleaved RGD (high) surfaces, and to a smaller degree on PEG18, and all RGE 
surfaces, creating a pronounced cell size difference between the surfaces. As morphology 
was altered, adhesion and cytoskeletal arrangement also changed with RGD controls and 
cleaved RGD (high) surfaces supporting more organized stress fibers and larger adhesions. 
Red = actin, green = vinculin and blue = nuclei. (B) Adhesion subtypes were recorded as a 
percentage of the average number of adhesions identified per cell. The majority of 
adhesions were focal adhesions (FAs), with focal complexes (FXs) and super-mature 
adhesions (SMAdhs) making up a much smaller percentage. As a whole, more FXs were 
observed per cell on plain, PEG18, RGE controls, FMOC-RGD (low) and cleaved RGE 
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substrates, while more SMAdhs were observed on RGD controls and cleaved RGD (high) 
surfaces. In line with differences in cell size and adhesion length, p-myosin expression, as a 
measure of cytoskeletal tension, showed the cells were under increased tension on RGD 
controls and cleaved RGD (high) surfaces. Error bars are standard error of the mean; stars 
indicate significant difference between groups as determined by one-way ANOVA and 
Dunn’s post hoc test where *P<0.5, **P<0.01 and ***P <0.001 - § = plain/PEG different to 
RGD by P<0.05; n= 40 cells per substrate and 3 material replicates. 
 
Figure 3: Integrin, BMP2 receptor and cytoskeletal tethering changes in MSCs on 
dynamic surfaces. (A) Integrin 1 and BMPR1a staining in MSCs cultured on FMOC-RGD 
(low) at t0 (t0 is after 48 hours of culture immediately before addition of elastase) and then 
after 24 and 48 hours post elastase treatment (cleaved RGD) or in FMOC-RGD surfaces. 1 
was observed to be found in punctate adhesions with little BMPR1a co-localisation noted 
(48 hours inset). On the cleaved RGD (high) surfaces, BMPR1a was seen with adhesion 
morphology but in different areas to the regions of 1 localisation (48 hours outset). (B) 
Integrin 5 and BMPR1a staining in MSCs on FMOC-RGD surfaces at t0 (immediately before 
addition of elastase) and then at 24 and 48 hours post–elastase (cleaved RGD) or in FMOC-
RGD surfaces. On the FMOC-RGD surfaces, little 5 expression and no BMPR1a co-
localisation was observed. However, on the cleaved surfaces, strong 5/BMPR1a co-
localisation was noted by 24 hours (outset images). (C) Actin/ezrin co-localisation could be 
seen at t0 and on FMOC-RGD. However, for cleaved RGD samples, ezrin appeared to co-
localise with cortical actin at the cell periphery (arrows). SiRNA knock-down of ezrin 
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resulted in an increase in pRUNX 2 5-days post switch. For pRNUX2, in-cell western 
analysis, n=3, results are meanSD, stats by ANOVA and Dunn’s post hoc test where * = 
p<0.05. 
 
Figure 4: Analysis of MSC growth and differentiation at days 7 and 21. (A) Panel shows 
immunofluorescence images of STRO-1 MSCs at day 21. At this time point, the STRO-1 
marker had substantially decreased on all surfaces, remaining only on plain controls and 
FMOC-RGD (low) surfaces (outset images). ALCAM was still easily detectible on the plain 
controls and FMOC-RGD but reduced on RGD controls and cleaved RGD (high) surfaces. 
OPN and OCN levels were increased on RGD controls and cleaved RGD with respect to the 
other surfaces. Red (actin), green = STRO-1/ALCAM/OPN/OCN and blue = nuclei; scale bar 
is 100 µm. (B) Graphs show quantification of STRO-1 expression at 7, 14 and 21 days of 
culture. At day 7, almost all cells on plain controls, FMOC-RGD and cleaved RGD surfaces 
expressed STRO-1. This reduced with time until, at day 21, less that 15% of cells on plain 
controls and the cleaved RGD surface retained STRO-1 expression while double this 
number, >30%, retained STRO-1 expression on FMOC-RGD (approx. 100 cells were 
included in the quantification; n=2). (C) OCN quantification. Data represents OCN levels 
expressed by MSCs cultured on plain glass, RGD controls, FMOC-RGD and cleaved RGD 
surfaces at day 7 and 21 of culture. OCN expression was observed to increase most on RGD 
controls and cleaved RGD compared to the other surfaces. (D) OPN quantification. Data 
represents OPN levels expressed by MSCs seeded on plain glass, RGD controls, FMOC-RGD 
and cleaved RGD at day 7 and 21 of culture. OPN expression was observed to increase most 
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on the RGD controls and cleaved RGD surfaces. Statistics carried out by one-way ANOVA 
and Dunn’s post hoc test where *P<0.05, **P<0.01 and ***P<0.001, n=3. Note that a.u = 
arbitrary units. 
 
Figure 5. Metabolite analysis of MSCs on dynamic surfaces. (A-C) Putative metabolites 
were analyzed using MetaboAnalyst 2.0 and the data was displayed as volcano plots 
relative to D2-plain (plain control at day 2). The y-axis refers to p-value (determined by 
two-tailed t-test), with the x-axis intercept set at P=0.05 so that all data points above the x-
axis represent metabolites that were significantly different from controls. The x-axis 
represents fold change as a measure of the magnitude in difference between samples and 
the control. Data points to the left of the y-axis are metabolites down regulated with 
respect to controls while data points on the right of the y-axis were up regulated (n=3). (D) 
At 7 days (2 days ‘low’, 5 days ‘high’ for cleaved RGD), principle component analysis 
showed very clear metabolomic differences with MSCs on the FMOC-RGD (low) surface 
having a highly homogeneous metabolome, more so than on the controls, and the cleaved 
RGD (high) surfaces having a far more heterogenous metabolome (n=3). (E) Heatmap of 
putatively detected unsaturated lipids after 7 days culture showing up-regulation in MSCs 
on the FMOC-RGD surface, and down-regulation in MSCs on the cleaved RGD surface (n=3). 
(F&G) Ingenuity® functional pathway analysis illustrating more, more significantly altered 
functional pathways in MSCs on the cleaved RGD surface (F) compared to those on FMOC-
RGD surfaces (G). Functions include carbohydrate, small molecule, nucleic acid, lipid and 
vitamin metabolism, cell growth and proliferation, and skeletal development pathways 
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(statistics by Fischer’s exact test – p<0.05 represented by bars higher than the threshold 
arrow, n=3). 
 
Figure 6. Analysis of MSC adhesion and differentiation on PEG blocked surfaces. (A) 
Panel shows Immunofluorescence images of vinculin in adhesions at day 5 and STRO-1 at 
day 21 of culture. On the PEG-RGD (low) substrates, MSCs were observed to have smaller 
adhesions and increased expression of the STRO-1 MSC marker (arrows) compared to 
MSCs seeded on RGD cleaved surfaces (high) where, again, larger adhesions and loss of 
STRO-1 expression was observed. Red = actin, green = vinculin or STRO-1 and blue = 
nucleus. (B) Image analysis after 21 days culture confirmed these results demonstrating 
that more MSCs retained STRO-1 expression on PEG-RGD than cells on plain controls and 
cleaved RGD surfaces which typically lose STRO-1 much faster (results are meanSD, 
statistics by ANOVA, *=p<0.05). (C) Principle component analysis from metabolomics data 
illustrates most data homogeneity on PEG-RGD surfaces and most heterogeneity on the 
cleaved RGD surface as with the FMOC blocked samples (n=3). 
 
 
 
 
 
